Molecular Characteristics and Radiosensitivity of Cervical Cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2400094628

Enrollment

Unknown

Registered

2024-12-25

Start date

2025-01-01

Completion date

Unknown

Last updated

2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Group A:None

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Pathohistological diagnosis of cervical cancer; 2.Overall survival(OS)of not less than 6 months; 3.Age >=18 years; 4.First time chemoradiotherapy; 5.Patients volunteered for the study,signed informed consent,and were approved by the ethics committee of the project.

Exclusion criteria

Exclusion criteria: 1. had received anti-cancer treatment within 6 months; 2. recurrence or metastasis; 3. the second-primary cancer; 4.severe comorbidity; 5. pregnancy or lactation.

Design outcomes

Primary

Measure	Time frame
molecular signature expression profile subtype;	—

Secondary

Measure	Time frame
ORR,Objective response rate;PFS,Progression-free survival;OS,Overall survival;	—

Countries

China

Contacts

Public ContactYunxiu Luo

Hainan Cancer Hospital

luoyunxiu@hnszlyy.wecom.work+86 898 36379999

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026